REFERENCES
- Wong R, Pavesio CE, Laidlaw DAH, et al. Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome. Ophthalmology. 2010;117:556–560.
- Roy R, Pal BP, Mathur G, et al. Acute retinal necrosis: clinical features, management and outcomes–a 10 year consecutive case series. Ocul Immunol Inflamm. 2014;22:170–174.
- Tibbetts MD, Shah CP, Young LH, et al. Treatment of acute retinal necrosis. Ophthalmology. 2010;117:818–824.
- Lau CH, Missotten T, Salzmann J, et al. Acute retinal necrosis: features, management, and outcomes. Ophthalmology. 2007;114:756–762.
- Fisher JP, Lewis ML, Blumenkranz M, et al. The acute retinal necrosis syndrome. Part 1. Clinical manifestations. Ophthalmology. 1982;89:1309.
- Palay DA, Sternberg P Jr, Davis J, et al. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. Am J Ophthalmol. 1991;112:250–255.
- Okunuki Y, Usui Y, Kezuka T, et al. Four cases of bilateral acute retinal necrosis with a long interval after the initial onset. Br J Ophthalmol. 2011;95:1251–1254.
- Dokey AT, Haug SJ, McDonald HR, et al. Acute retinal necrosis secondary to multidrug-resistant herpes simplex virus 2 in an immunocompetent adolescent. Retin Cases Brief Rep. 2014;8:260–264.
- Khurana RN, Charonis A, Samuel MA, et al. Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children. Med Sci Monit. 2005;11:CS75–78.
- Piret J, Boivin G. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrobial Agents Chemotherapy. 2011;55:459–472.
- Andrei G, Topalis D, Fiten P, et al. In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs. J Virol. 2012; 86:2641–2652.
- Duan R, de Vries RD, Osterhaus ADME, et al. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis. J Infect Diseases. 2008;198:659–663.
- Aoki FY. Antivirals against herpes viruses. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th Edition. Elsevier Saunders, Philadelphia, PA, 2015.
- Huynh TH, Johnson MW, Comer GM, et al. Vitreous penetration of orally administered valacyclovir. Am J Ophthalmol. 2008;145:682–686.
- Arevalo JF, Gonzalez C, Capparelli EV, et al. Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis.. J Infect Diseases. 1995;172:951–956.
- Lopez-Cortes LF, Ruiz-Valderas R, Lucero-Munoz MJ, et al. Intravitreal, retinal, and central nervous system foscarnet concentrations after rapid intravenous administration to rabbits. Antimicrob Agents Chemotherapy. 2000;44:756–759.
- Moorthy RS, Weinberg DV, Teich SA, et al. Management of varicella zoster virus retinitis in AIDS. Br J Ophthalmol. 1997;81:189–194.
- Wong RW, Jumper JM, McDonald HR, et al. Emerging concepts in the management of acute retinal necrosis. Br J Ophthalmol. 2013;97:545–552.
- Chau Tran TH, Cassoux N, Bodaghi B, et al. Successful treatment with combination of systemic antiviral drugs and intravitreal ganciclovir injections in the management of severe necrotizing herpetic retinitis. Ocul Immunol Inflamm. 2003;11:141–144.
- Luu KKM, Scott IU, Chaudhry NA, et al. Intravitreal antiviral injections as adjunctive therapy in the management of immunocompetent patients with necrotizing herpetic retinopathy. Am J Ophthalmol. 2000;129:811–813.
- Zambarakji HJ, Obi AA, Mitchell SM. Successful treatment of varicella zoster virus retinitis with aggressive intravitreal and systemic antiviral therapy. Ocul Immunol Inflamm. 2001;10:41–46.